Verastem CEO Daniel Paterson to Retire, Remain as Advisor and Board Member
Verastem says Daniel Paterson will retire as president and CEO and remain as an advisor and board member.
Story updates
10:13:20 AM UTC
SquawkNews
Verastem appointed Michael Bailey as President and Chief Executive Officer, effective January 1, 2027, as Daniel W. Paterson retires from the CEO role and will remain on the board.Original SEC Filing: Verastem, Inc. [ VSTM ] - 8-K - Oct. 14, 2026This is an AI-powered summary. It may contain inaccur…
10:19:46 AM UTC
SquawkNews
By Colin KellaherVerastem's president and chief executive, Daniel Paterson, is retiring at the end of the year and will be succeeded at the helm of the biopharmaceutical company by board member Michael Bailey.Verastem on Wednesday said Bailey, who joined the board in January 2015, will become presi…